drugset / Trial / NCT00318630

The Effect Of AVANDIA On The Late Asthmatic Response

NCT00318630

Phase 1 Completed 26 enrolled GlaxoSmithKline
RandomizedCrossoverTreatment

Summary

This study is to investigate the effects of AVANDIA on the asthmatic response.

Timeline

Start
2005-07-22
Primary completion
2006-06-30
Completion
2006-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosiglitazone Small molecule 4 mg Oral

Indications